drugset / Trial / NCT04251364
Treatment of Chronic Mountain Sickness
RandomizedParallel-groupTriple-blindTreatment
Summary
This study aims to assess the effect of two drugs for the treatment of chronic mountain sickness in highlanders.
Timeline
- Start
- 2020-02-15
- Primary completion
- 2021-10-30
- Completion
- 2021-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetazolamide | Small molecule | 250 mg | Oral |
| Subject | Atorvastatin | Small molecule | 40 mg | Oral |